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The growth plate lacks vascular tissues and 
is solely composed of chondrocytes. The 
growth plate is composed of three layers, 
i.e., the resting, proliferating and hyper-
trophic chondrocyte layers. The chon-
drocytes in the resting and proliferating 
layers proliferate and then they uniformly 
maturate toward the diaphysis to become 
hypertrophic chondrocytes, which lose the 
ability to proliferate. As the growth plate 
lacks vasculature, apoptotic chondrocytes 
are not phagocytosed, and the fragmented 
DNA detected by TUNEL remains until 
they reach the bone marrow. Therefore, 
the growth plate is an appropriate tissue 
to use for evaluation of cell proliferation, 
differentiation, and apoptosis.
We examined the effects of Cdk6 
and Ccnd1 (cyclin D1) in chondrocyte 
proliferation, differentiation, and apop-
tosis.1 Transgenic mice overexpressing 
either Cdk6 or Ccnd1 in chondrocytes 
show no increase in the number of BrdU-
positive cells, and the chondrocytes nor-
mally maturate, although CCND1 is a 
well-established human oncogene. In 
contrast, transgenic mice overexpressing 
both Cdk6 and Ccnd1 show dwarfism. 
In Cdk6/Ccnd1 double transgenic mice, 
chondrocyte maturation to hypertrophic 
chondrocytes is inhibited, and the num-
ber of BrdU-positive cells is increased, 
but the proliferation of chondrocytes is 
not enhanced, and the frequency of apop-
totic chondrocytes is greatly increased. 
The apoptosis is rescued by p53 deletion, 
but chondrocyte proliferation is still not 
enhanced in p53–/–Cdk6/Ccnd1 double 
transgenic mice.
Cdk6 and Ccnd1 regulate the activ-
ity of E2fs by phosphorylating Rb family 
proteins, Rb, p107, and p130, and trigger 
progression through the G0/G1 and G1/S 
transitions of the cell cycle. The effects 
of targeted deletions of Rb family genes 
in chondrocytes were reported by two 
groups.2-4 p107-knockout mice show most 
apparent inhibition of chondrocyte dif-
ferentiation among the knockout mice of 
Rb family genes. Double knockout mice 
of p107/p130 or p107/Rb show more severe 
inhibition of chondrocyte differentiation 
and chondrocyte proliferation is enhanced 
without an increase in chondrocyte apop-
tosis. Therefore, all of the Rb family 
proteins are involved in chondrocyte pro-
liferation and differentiation, and p107 
plays a major role among them.
When we generated Cdk6/Ccnd1 
double transgenic mice, we expected that 
overexpression of both Cdk6 and Ccnd1 
would result in the inactivation of all 
Rb family proteins by their phosphoryla-
tion. However, the phenotype of Cdk6/
Ccnd1 double transgenic mice was dif-
ferent from those of p107/p130 or p107/
Rb double knockout mice. BrdU-positive 
cells are increased, and chondrocyte dif-
ferentiation is inhibited in p107/p130 and 
p107/Rb double knockout mice and Cdk6/
Ccnd1 double transgenic mice. However, 
chondrocyte proliferation is enhanced 
without an increase in apoptosis in p107/
p130 and p107/Rb double knockout mice, 
whereas chondrocyte proliferation is not 
enhanced, and apoptotic chondrocytes are 
greatly increased in Cdk6/Ccnd1 double 
transgenic mice. In Cdk6/Ccnd1 double 
transgenic mice, Rb but not p107 is highly 
phosphorylated, and mRNA and protein 
levels of p107 are increased.1 p107 tran-
scription is regulated by E2f, and p107 is 
upregulated in Rb–/– and p130–/– mouse 
embryonic fibroblasts.5-7 Therefore, the 
phenotypic differences between p107/
p130 and p107/Rb double knockout mice 
and Cdk6/Ccnd1 double transgenic mice 
could be explained by the absence or pres-
ence of p107.
When Cdk6 and Ccnd1 are overex-
pressed, Rb, p107, and p130 should be 
phosphorylated, leading to the release of 
repressing E2fs (E2f4, 5) and activation of 
activating E2fs (E2f1–3), both of which 
enhance the transcription of E2f target 
genes including p107 (Fig. 1A and B). 
Therefore, phosphorylation of Rb, p107, 
and p130 enhances the transcription of 
p107 by E2f and unphosphorylated p107 is 
continuously supplied. This is the reason 
why unphosphorylated p107 is dominant 
in Cdk6/Ccnd1 double transgenic mice.1 
Although p107 binds to repressing E2fs 
at the physiological condition, upregula-
tion of p107 allows complex formation of 
activating E2fs with p107.8 Therefore, the 
increased amount of unphosphorylated 
p107 associates not only with repress-
ing E2fs, but also with activating E2fs 
(Fig. 1C). As p107 plays a major role in 
cell cycle regulation among Rb family 
proteins in chondrocytes, the association 
of p107 with repressing and activating 
E2fs would affect the expression of E2f 
target genes. It occurs in Cdk6/Ccnd1 
double transgenic mice as shown by the 
downregulation of cyclin E, dhfr, cdc25a, 
and B-Myb. Further, chondrogenic 
ATDC5 cells overexpressing Cdk6 and 
Ccnd1 also had downregulated expres-
sion of these genes, and siRNA of p107 
reversed the downregulated expression of 
these genes. Therefore, phosphorylation 
of Rb, p107, and p130 upregulates p107 
expression, which dysregulates E2f target 
gene expression leading to p53-dependent 
apoptosis (Fig. 1B and C). p53 deletion 
in addition to Rb inactivation is still not 
sufficient for enhancement of chondrocyte 
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proliferation, suggesting that p107 con-
tributes to the low incidence of chondro-
sarcoma as an anti-oncogenic protein, 
because the frequency of chondrosarcoma 
is much less than those of sarcomas arising 
in soft tissues.
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Figure 1. regulation of rb family proteins by Cdk6/Ccnd1. (A) rb, p107, and p130 associate with 
repressing E2fs (E2f4 and E2f5) which are located in the cytoplasm, the complexes translocate to 
the nucleus, and they bind to E2f target genes and inhibit their expression (left). rb associates 
with activating E2fs (E2f1, E2f2, and E2f3) and inhibits the activity of E2fs (right). (B) overexpres-
sion of Cdk6 and Ccnd1 phosphorylates rb, p107, and p130, the phosphorylated rb, p107, and 
p130 dissociate from the repressing E2fs, and the E2fs translocate to the cytoplasm (left). the 
phosphorylated rb dissociates from the activating E2fs, and the E2fs are activated (right). in both 
cases, the repression of genes necessary for progression through the cell cycle is lifted. However, 
the expression of p107, which is regulated by E2f, is also upregulated. (C) unphosphorylated p107 
associates with repressing E2fs and suppresses the expression of E2f target genes (left). unphos-
phorylated p107 also associates with activating E2fs and inhibits them (right). in both cases, the 
expression of E2f target genes is inhibited and the dysregulation of E2f target genes results in 
p53-dependent apoptosis.
